FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Clinical trials for FOCAL SEGMENTAL GLOMERULOSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new FOCAL SEGMENTAL GLOMERULOSCLEROSIS trials appear
Sign up with your email to follow new studies for FOCAL SEGMENTAL GLOMERULOSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in slowing kidney disease for FSGS patients
Disease control CompletedThis study tested a new medicine called sparsentan in 371 people with a rare kidney disease called FSGS. The goal was to see if it could slow down kidney damage better than a standard treatment. Participants took either sparsentan or a standard blood pressure pill, and researcher…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Phase: PHASE3 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New drug R3R01 targets protein leak in tough kidney diseases
Disease control CompletedThis study tested a new drug, R3R01, in 43 people with Alport syndrome or a kidney condition called focal segmental glomerulosclerosis (FSGS) who still had protein in their urine despite standard treatment. The main goals were to check the drug's safety and see if it could reduce…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Phase: PHASE2 • Sponsor: River 3 Renal Corp. • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
New hope for FSGS patients: preemptive treatment may prevent kidney disease return
Prevention CompletedThis early-phase study tested whether giving a combination of plasmapheresis (a blood-filtering procedure) and the drug rituximab before or at the time of kidney transplant could prevent focal segmental glomerulosclerosis (FSGS) from coming back. The trial enrolled 21 children an…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Phase: EARLY_PHASE1 • Sponsor: University of Minnesota • Aim: Prevention
Last updated May 17, 2026 05:35 UTC
-
Gene hunt for kidney disease FSGS aims to unlock early detection
Knowledge-focused CompletedThis study looked for genetic factors that may cause focal segmental glomerulosclerosis (FSGS), a kidney disease that can lead to kidney failure. Researchers compared DNA from 616 people, including African-Americans with FSGS, African-Americans with HIV but no FSGS, and non-Afric…
Matched conditions: FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC